๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Retracted Fenoldopam in critically ill patients with early renal dysfunction: A crossover study

โœ Scribed by Gian Paparcuri; Miguel Cobas; Maria De La Pena; Erik Barquist; Albert Varon


Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
98 KB
Volume
40
Category
Article
ISSN
0090-2934

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Retraction: The following article from Dialysis & Transplantation, 'Fenoldopam in critically ill patients with early renal dysfunction: A crossover study' by Gian Paparcuri, Miguel Cobas, Maria De La Pena, Erik Barquist and Albert Varon, published online on March 8, 2011 in Wiley Online Library (wileyonlinelibrary.com), and in Volume 40, pp. 164โ€167, has been retracted through agreement between the first author, the Editors, Andrew Z. Fenves and Larry B. Melton, and Wiley Periodicals, Inc. The retraction has been agreed due to duplicate publication in another journal.


๐Ÿ“œ SIMILAR VOLUMES


Molecular adsorbent recirculating system
โœ Hubert Hetz; Peter Faybik; Gabriela Berlakovich; Amir Baker; Andreas Bacher; Chr ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

Early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT) causes marked morbidity and mortality. We conducted a prospective pilot study to assess the safety and efficacy of molecular adsorbent recirculating system (MARS) in treatment of EAD after OLT. Twelve consecutive adult li

Single-fiber electromyography, nerve con
โœ Johannes Schwarz; Johannes Planck; Josef Briegel; Andreas Straube ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB ๐Ÿ‘ 1 views

Nine patients at risk for critical illness polyneuropathy (CIP) were included in a prospective study. We performed nerve conduction studies, electromyography, and a stimulation single-fiber electromyography (SFEMG). Five of 9 patients were diagnosed as CIP because they developed abnormal spontaneous

Phase II study of paclitaxel plus carbop
โœ David J. Vaughn; Judith Manola; Robert Dreicer; William See; Ralph Levitt; Georg ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

## Background: Chemotherapy options for the patients with advanced urothelial carcinoma and renal dysfunction are limited. the authors performed a phase ii trial of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction. ## Methods: Forty-two patie